Answers are grounded in this paper and cite their sources.
Fig 1.The cellular m 6 A machinery.N6-methyladenosine (m 6 A) is a reversible RNA modification that occurs in cellular and viral RNA.The deposition of m 6 A at the consensus motif DRAmCH (where D = G/A/U, R = G > A, and H = U/C/A) is governed by a cellular methyltransferase complex composed of the "writers" METTL3 and METTL14, and other noncatalytic cofactors.m 6 A modification can be reversed by the "erasers" FTO and ALKBH5.*We note that FTO has recently been found to have greater specificity for the m 6 Am modifications present in mRNA cap structures than for m 6 A [34]. "Reader" m 6 A-specific RNA binding proteins, including the cytoplasmic YTHDF1, YTHDF2, YTHDF3, and nuclear YTHDC1 control the function of m 6 A on RNA.YTHDF1 promotes translation of cellular m 6 A-mRNAs, while YTHDF2 targets them for degradation.YTHDC1 regulates the splicing of m 6 A-modified pre-mRNA.The role of m 6 A and the m 6 A machinery in RNA function and biological processes is further reviewed in [2].
No takes yet. Share an insight, caveat, or question.
Gokhale et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: